Breaking the wave of peri‐implantitis
Periodontology 20002020Vol. 84(1), pp. 145–160
Citations Over TimeTop 1% of 2020 papers
Abstract
Peri-implant diseases are prevalent with a weighted mean prevalence rate of 43% across Europe and 22% across South and North America. Although the main etiologic agent is bacterial biofilm, a myriad of factors influence the initiation and progression of the disease. Unfortunately, the treatment of peri-implant diseases is at best favorable in the short term with a high rate of persistent inflammation and recurrence. Therefore, it is sensible to consider and control all potential factors that may predispose an implant to peri-implant tissue inflammation in an attempt to avoid the disease. This paper reviews recent evidence on factors that may predispose implants to peri-implantitis and measures that can be taken to prevent it.
Related Papers
- → Clinical and microbiological findings in patients with peri‐implantitis: a cross‐sectional study(2015)127 cited
- → Diffuse Large B-Cell Lymphoma of the Peri-Implant Mucosa Mimicking Peri-Implantitis(2015)6 cited
- → Change in bone resorption markers in peri-implant sulcus fluid after surgical treatment of peri-implantitis(2012)
- → Peri-Implant Diseases: Peri-implant Mucositis And Peri-implantitis(2017)